Spectrascience gets guidewire patent:
This article was originally published in Clinica
Executive Summary
Spectrascience has received a US patent for its spectroscopic coronary guidewire system. The guidewire, which uses laser-induced fluorescence to analyse atherosclerotic plaque before interventional treatment, is licensed from the Massachusetts Institute of Technology.